| Title | Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer | ||
|---|---|---|---|
| Disease/Condition | Lung Cancer | ||
| Description | Eligibility Criteria | Ages Eligible for Study: 18 Years and older (Adult, Senior) Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements | |
| Principal Investigator | Haiying Cheng, MD | ||
| Contact Name | Karen Fehn, RN | ||
| Phone | (718) 405-8446 | ||
| Contact Email | CPDMUtrialinfo@montefiore.org | ||
| Protocol Number | IRB# 2016-6220 | ||
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. | ||
| Status | Enrolling | ||
| Adult Clinical Trial | Yes | ||
| Pediatric Clinical Trial | No | ||
| Adult, Pediatric, Both | Adult |